Home › Breast Carcinoma In Situ
Breast Carcinoma In Situ clinical trials recruiting in the U.S.
20 studies for Breast Carcinoma In Situ are recruiting participants at sites across the United States.
Cities with the most studies
- Columbus, OH5 studies
- Jacksonville, FL4 studies
- New York City, NY4 studies
- Boston, MA4 studies
- Philadelphia, PA3 studies
- Ann Arbor, MI3 studies
- Chicago, IL3 studies
- Kansas City, KS3 studies
By state
- California5 studies
- Florida5 studies
- Illinois4 studies
- Kansas3 studies
- Massachusetts4 studies
- Michigan4 studies
- New York4 studies
- Ohio6 studies
- Pennsylvania4 studies
Recently updated studies
CAN1012 in Pre-Malignant DCIS and LCIS
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07408856Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RecruitingHealthy volunteers welcome
Ages 30 to 74 · Women · Updated Sep 21, 2026 · NCT02620852Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 19, 2026 · NCT06153836Optimizing Surgical Decisions in Young Adults With Breast Cancer
Recruiting
Ages 18 to 44 · Women · Updated Aug 19, 2026 · NCT06275126A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors
Recruiting
Ages 18 and older · Women · Updated Aug 14, 2026 · NCT076999915-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 10, 2026 · NCT07044310Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
RecruitingPhase 2Healthy volunteers welcome
Ages 45 to 74 · Women · Updated Aug 4, 2026 · NCT06195306Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RecruitingPhase 2
Ages 35 and older · Women · Updated Jul 7, 2026 · NCT05941520Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05178498Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
Recruiting
Ages 18 and older · Women · Updated Jun 5, 2026 · NCT06297265Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
RecruitingObservational study
Ages 18 and older · Women · Updated May 19, 2026 · NCT06401889A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
RecruitingPhase 2Healthy volunteers welcome
All ages · All sexes · Updated Apr 24, 2026 · NCT07443943The PREDICT Registry:
RecruitingObservational study
Ages 30 to 85 · Women · Updated Apr 17, 2026 · NCT03448926CONFIRM: Magnetic Resonance Guided Radiation Therapy
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT04368702A Study of Revaree Plus in People With Breast Cancer
RecruitingPhase 4
Ages 18 and older · Women · Updated Feb 6, 2026 · NCT07042581EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Recruiting
Ages 20 to 89 · Women · Updated Feb 4, 2026 · NCT06115486Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Recruiting
Ages 40 and older · All sexes · Updated Jan 23, 2026 · NCT04959474Prospective Breast Cancer Biospecimen Collection
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 3, 2025 · NCT04074720Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 16, 2024 · NCT04603209From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.